Cambridge Innovation Capital has backed a round sized at up to $50m for disease testing kit producer Sense Biodetection, which has now raised more than $64m altogether.

The AIG, Illumina, Alphabet and Orient Life-backed cell therapy developer priced its shares at the bottom of the range to raise $70.6m.

Legend Capital returned to reinvest in a $34.4m round for pathogen testing services provider Genskey, lifting its total funding above $55m.

The 3D-printed product supplier raised an eight-digit dollar amount in a round featuring Chinese Academy of Sciences.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Genetic testing company Prenetics leveraged a UK-based subsidiary to buy Oxsed having piloted the latter's rapid coronavirus screening system.

Lilly Asia Ventures contributed to a round that will fund clinical trials for Carsgen's immuno-oncology drug pipeline and the enhancement of its manufacturing capabilities.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

The Heska-backed company is currently working on a covid-19 test, its latest round having pushed its total equity funding to about $30m.

University of Colorado and Osage University Partners both backed a round that took the immune regulation-focused university spinout's total funding to at least $106m.